Cargando…

Dihydromyricetin Protects Intestinal Barrier Integrity by Promoting IL-22 Expression in ILC3s through the AMPK/SIRT3/STAT3 Signaling Pathway

Background: Previous studies indicate that dihydromyricetin (DHM) could alleviate intestinal inflammation and improve intestinal barrier integrity, yet the underlying mechanism remains obscure. Methods: C57BL/6 male mice were fed with a control diet, high-fat diet (HFD), or HFD + DHM diet for 12 wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Yue, Jing, Yao, Yu, Hou, Pengfei, Zhang, Ting, Zhang, Qianyong, Yi, Long, Mi, Mantian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861697/ https://www.ncbi.nlm.nih.gov/pubmed/36678226 http://dx.doi.org/10.3390/nu15020355

Ejemplares similares

Dihydromyricetin Attenuates High-Intensity Exercise-Induced Intestinal Barrier Dysfunction Associated with the Modulation of the Phenotype of Intestinal Intraepithelial Lymphocytes
por: Hou, Pengfei, et al.
Publicado: (2022)

Dihydromyricetin attenuates palmitic acid-induced oxidative stress by promoting autophagy via SIRT3-ATG4B signaling in hepatocytes
por: Huang, Li, et al.
Publicado: (2021)

Dihydromyricetin Enhances Exercise-Induced GLP-1 Elevation through Stimulating cAMP and Inhibiting DPP-4
por: Wu, Luting, et al.
Publicado: (2022)

Dihydromyricetin-Encapsulated Liposomes Inhibit Exhaustive Exercise-Induced Liver Inflammation by Orchestrating M1/M2 Macrophage Polarization
por: Zhou, Xi, et al.
Publicado: (2022)

Inflammation triggers ILC3 patrolling of the intestinal barrier
por: Jarade, Angélique, et al.
Publicado: (2022)

Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation
por: Wei, Liping, et al.
Publicado: (2019)

SIRT3 Activation by Dihydromyricetin Suppresses Chondrocytes Degeneration via Maintaining Mitochondrial Homeostasis
por: Wang, Jianle, et al.
Publicado: (2018)

Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down‐regulation of phosphorylation of PPARγ in 3T3‐L1 cells
por: Liu, Lei, et al.
Publicado: (2017)

Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
por: Zhang, Yunshu, et al.
Publicado: (2023)

Epithelial IKKα licenses ILC3s to defend the intestinal barrier
por: Eftychi, Christina, et al.
Publicado: (2015)

Protective role of Dihydromyricetin in Alzheimer’s disease rat model associated with activating AMPK/SIRT1 signaling pathway
por: Sun, Ping, et al.
Publicado: (2019)

IL-15 sustains IL-7R-independent ILC2 and ILC3 development
por: Robinette, Michelle L., et al.
Publicado: (2017)

Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier
por: Talbot, Jhimmy, et al.
Publicado: (2020)

ILC2s are the predominant source of intestinal ILC-derived IL-10
por: Bando, Jennifer K., et al.
Publicado: (2019)

3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation
por: Peng, Xiaoli, et al.
Publicado: (2017)

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway
por: Li, Zhen, et al.
Publicado: (2022)

Bacteroides fragilis strain ZY-312 facilitates colonic mucosa regeneration in colitis via motivating STAT3 signaling pathway induced by IL-22 from ILC3 secretion
por: Zhang, Wendi, et al.
Publicado: (2023)

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect
por: Zhou, Xi, et al.
Publicado: (2021)

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
por: Pickert, Geethanjali, et al.
Publicado: (2009)

Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection
por: Lin, Yang-Ding, et al.
Publicado: (2019)

Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner
por: Hua, Yu-Yun, et al.
Publicado: (2020)

Dihydromyricetin Protects Against Gentamicin-Induced Ototoxicity via PGC-1α/SIRT3 Signaling in vitro
por: Han, Hezhou, et al.
Publicado: (2020)

Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway
por: Huang, Yujie, et al.
Publicado: (2019)

FGF21 Depletion Attenuates Colitis through Intestinal Epithelial IL-22-STAT3 Activation in Mice
por: Liu, Liming, et al.
Publicado: (2023)

Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma
por: Fan, Teng-Fei, et al.
Publicado: (2016)

Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway
por: Zhou, Yong, et al.
Publicado: (2016)

Dihydromyricetin Attenuates Myocardial Hypertrophy Induced by Transverse Aortic Constriction via Oxidative Stress Inhibition and SIRT3 Pathway Enhancement
por: Chen, Yun, et al.
Publicado: (2018)

The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway
por: Ratsimandresy, Rojo A, et al.
Publicado: (2017)

Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3
por: Yin, Shengxia, et al.
Publicado: (2018)

ILC3s protect intestinal stem cells from chemotherapy
por: Eberl, Gérard
Publicado: (2015)

Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
por: Stojanović, Ivana, et al.
Publicado: (2021)

Ornithine decarboxylase supports ILC3 responses in infectious and autoimmune colitis through positive regulation of IL-22 transcription
por: Peng, Vincent, et al.
Publicado: (2022)

3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway
por: Chen, Junli, et al.
Publicado: (2016)

Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling
por: Wang, Lu, et al.
Publicado: (2020)

Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion
por: Muraoka, Wayne T., et al.
Publicado: (2020)

Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation
por: Li, Jingyu, et al.
Publicado: (2019)

Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis
por: Wang, Baomei, et al.
Publicado: (2019)

Glycyrrhizin improves the pathogenesis of psoriasis partially through IL-17A and the SIRT1-STAT3 axis
por: Qiong, Huang, et al.
Publicado: (2021)

P2RY13 Exacerbates Intestinal Inflammation by Damaging the Intestinal Mucosal Barrier via Activating IL-6/STAT3 Pathway
por: Wu, Xiaohan, et al.
Publicado: (2022)

IL-22 is related to development of human colon cancer by activation of STAT3
por: Jiang, Runqiu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v2dcr0v8eachkh47v8ue8ofgp4